Alkaline phosphatase decline and pain response as predictors of overall survival benefit in patients treated with radium-223: a post hoc analysis of the REASSURE study.
British journal of cancer
View this publicationBritish journal of cancer
View this publicationHaematologica
View this publicationNeuro-oncology advances
View this publicationAllergy
View this publicationScientific reports
View this publicationCell reports
View this publicationJAMA
View this publicationEMBO molecular medicine
View this publicationEuropean journal of medical research
View this publicationScientific reports
View this publication